⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelodysplastic Syndrome Low Risk

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelodysplastic Syndrome Low Risk

Official Title: Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Low or Intermediate-1 Myelodysplastic Syndrome: A Prospective Multicenter Phase II Study Based on Donor Availability on Behalf of the GFM & SFGM-TC

Study ID: NCT02757989

Conditions

MDS

Interventions

transplantation

Study Description

Brief Summary: Comparison of survival in patients with or without a matched donor at 36 months

Detailed Description: Patients with a matched donor (8/8 at molecular level unrelated donor or matched sibling) received an allogeneic hematopoietic stem cell transplantation. Patients without a matched donor received the best available treatment. All patients will be followed at least 36 months or until the end of the study.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

CHU d'Amiens, Amiens, , France

CHU d'Angers, Angers, , France

Centre hospitalier Victor Dupouy, Argenteuil, , France

CHU Jean Minjoz, Besançon, , France

Hôpital Avicenne, Bobigny, , France

CHU de Haut Lévèque, Bordeaux, , France

CHRU Côte de Nacre, Caen, , France

CHU Estaing, Clermont Ferrand, , France

CHSF Gilles de Corbeil, Corbeil-Essonnes, , France

Hôpital Henri Mondor, Créteil, , France

CHU de Grenoble, Grenoble, , France

CH Le Mans, Le Mans, , France

Hôpital Saint Vincent de Paul, Lille, , France

Hôpital Huriez, Lille, , France

Hôpital Dupuytren, Limoges, , France

Centre hospitalier Lyon Sud, Lyon, , France

GHEF, site de Meaux, Meaux, , France

CHRU de Montpellier, Montpellier, , France

CHU de Nantes, Nantes, , France

CHU de Nice, Nice, , France

CHU de Nîmes, Nîmes, , France

Hôpital Saint Louis, Paris, , France

Hôpital Pitié Salpétrière, Paris, , France

Hôpital Cochin, Paris, , France

Hôpital Necker, Paris, , France

CH Joffre, Perpignan, , France

CHU de Poitiers, Poitiers, , France

CH René Dubos, Pontoise, , France

CHU de Reims, Reims, , France

Hôpital Pontchaillou, Rennes, , France

Centre Henri Becquerel, Rouen, , France

Institut Curie, Saint-Cloud, , France

Institut de cancérologie Lucien Neuwirth, Saint-Priest-en-Jarez, , France

Hôpital civil, Strasbourg, , France

IUCT-Oncopole, Toulouse, , France

Hôpital Bretonneau, Tours, , France

Hôpital de Brabois, Vandoeuvre les nancy, , France

Contact Details

Name: Marie Robin, MD

Affiliation: Saint-Louis Hospital, Paris, France

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: